ATM

Advertisement
Aug 06 2025HEALTH

Unlocking the Secrets of Chronic Pain: Why Treatments Lag Behind Science

Chronic pain affects millions, yet treatments haven't kept up with scientific advances. Experts agree that we know more than ever about pain, but the healthcare system isn't set up to deliver the right care. Nearly one in four adults struggles with chronic pain, a number that's been rising since 201

reading time less than a minute
Aug 04 2025HEALTH

Examining TV-46000: A Closer Look at Safety in Schizophrenia Treatment

TV-46000 is a new drug for schizophrenia. It is given as an injection under the skin. The drug is based on risperidone, which is already used to treat schizophrenia. Two big tests, called RISE and SHINE, were done to check how safe TV-46000 is. These tests looked at different side effects. They che

reading time less than a minute
Jul 31 2025HEALTH

A New Hope for Bone Infections: The Power of Smart Hydrogels

Bone infections are tough to treat. Bacteria form protective biofilms. They become resistant to many drugs. Antibiotics struggle to reach deep into infected bones. This slows down healing and makes the problem worse. Scientists have created a smart hydrogel. It is called CMBG. It is made from natur

reading time less than a minute
Jul 30 2025HEALTH

Hospital Certifications and Racial Gaps in Stroke Care

Hospitals getting certified for stroke care is a big deal. It means they have the right tools and know-how to treat strokes better. But does this help all patients equally? That's the big question. Black and White patients might not be getting the same benefits from these certified stroke centers.

reading time less than a minute
Jul 30 2025HEALTH

Pregnant Women's Health at Risk Due to Penicillin Shortage

A critical shortage of a key antibiotic is raising concerns about the health of pregnant women. Pfizer, a major pharmaceutical company, has announced that it will have limited supplies of Bicillin LA. This drug is crucial for treating syphilis in pregnant women. The shortage comes after Pfizer recal

reading time less than a minute
Jul 30 2025HEALTH

Understanding Brodalumab: A Seven-Year Safety Review

Brodalumab is a medication that targets a specific protein in the body. It is used to treat adults with severe skin conditions, such as plaque psoriasis, when other treatments have not worked. However, it carries a significant warning about potential mental health risks. For the past seven years, r

reading time less than a minute
Jul 30 2025HEALTH

Deciding on Extra Treatment for Prostate Cancer

Prostate cancer treatment isn't always straightforward. After surgery, some patients might need additional treatment. This is because cancer cells can sometimes linger, leading to what doctors refer to as a biochemical recurrence. It's like trying to get rid of weeds in a garden, but some roots rema

reading time less than a minute
Jul 29 2025HEALTH

Smart Bubbles for Fighting Cancer and Seeing Inside Cells

Mitochondria are like tiny powerhouses inside our cells. They keep us going, but sometimes they go wrong and cause problems. Tiny molecules called miRNAs help control these powerhouses. Scientists have been trying to find ways to see and fix these miRNAs to help treat diseases like cancer. A new id

reading time less than a minute
Jul 29 2025SCIENCE

Gene Mix-Up and Cancer's Drug Defense

Cancer is a tricky foe, always finding ways to dodge treatments. One type, Ewing sarcoma, often affects young people. It's caused by a gene fusion called EWS::FLI1. This fusion acts like a commander, driving cancer cells to multiply uncontrollably. Scientists made a surprising find. EWS::FLI1 disru

reading time less than a minute
Jul 25 2025HEALTH

A New Hope for HIV Treatment: South African Men's Take on Long-Acting Injections

In South Africa, men who are not straight face big problems with HIV. They have a hard time sticking to their daily HIV medicine. This makes it tough to keep the virus under control. Things like hiding their status, feeling ashamed, and dealing with partners make it even harder. A new kind of HIV m

reading time less than a minute